Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016

• Published in: Journal of market access & health policy Vol. 5; no. 1; pp. 1360545 - 10
• Main Authors: Drake, Julia I., de Hart, Juan Carlos Trujillo, Monleón, Clara, Toro, Walter, Valentim, Joice
• Format: Journal Article
• Language: English
• Published: United States Routledge 2017; Taylor & Francis Ltd; Taylor & Francis Group
• Subjects: Cost analysis; Criteria; Decision analysis; Decision making; Fairness; Health care; Health services; HTA; Innovations; Literature reviews; MCDA; Other; Pharmaceutical industry; Position Paper; Private sector; Technology assessment; Latin America; HTA; MCDA
• ISSN: 2001-6689; 2001-6689
• DOI: 10.1080/20016689.2017.1360545

Background and objectives:   MCDA is a decision-making tool with increasing use in the healthcare sector, including HTA (Health Technology Assessment). By applying multiple criteria, including innovation, in a comprehensive, structured and explicit manner, MCDA fosters a transparent, participative, consistent decision-making process taking into consideration values of all stakeholders.
This paper by FIFARMA (Latin American Federation of Pharmaceutical Industry) proposes the deliberative (partial) MCDA as a more pragmatic, agile approach, especially when newly implemented.
Methods: Literature review including real-world examples of effective MCDA implementation in healthcare decision making in both the public and private sector worldwide and in LA.
Results and conclusion: It is the view of FIFARMA that MCDA should strongly be considered as a tool to support HTA and broader healthcare decision making such as the contracts and tenders process in order to foster transparency, fairness, and collaboration amongst stakeholders.